Regulation & Compliance

AVEO Oncology's ficlatuzumab advances in a pivotal Phase 3 trial, offering new hope for patients with a difficult-to-treat form of head and neck cancer.

Vasion's FedRAMP High ATO, sponsored by DISA, unlocks secure AI-driven document automation for federal agencies, validating its cloud-native platform.

Thousands of NC homeowners are now free from MV Realty's deceptive 40-year contracts after a landmark court victory hailed by consumer advocates.

With over $100M in revenue, Starburst's federated AI platform is challenging the old data warehouse model, especially in high-stakes finance.

A new exclusive partnership will streamline access to a key ingredient, fueling innovation in beauty and cleaning products across Europe, the Middle East, and Africa.

AcuityMD's new Salesforce integration promises to eliminate data silos and boost sales for MedTech firms, marking a strategic leap for the AI unicorn.

A new AI-native system, Isaac PracticeOS, promises to replace up to ten dental software tools, automating claims, scheduling, and patient communications.

Grown Rogue will report 2025 results on March 31, transitioning to U.S. GAAP to boost transparency and consolidate its key New Jersey operations.

As AI risks grow, companies like Cycore are racing to offer unified compliance solutions for a complex and costly web of new global regulations.

The bitcoin financial services firm is now a CFTC-registered Commodity Trading Advisor, a move signaling a new era of compliance for institutional crypto.

A new biotech emerges with massive funding and a next-gen 'shuttle' to deliver safer, more effective Alzheimer's therapies directly to the brain.

As agentic AI adoption accelerates, Cloud Range's new platform offers a secure environment for organizations to test and validate AI models before deployment.

The 'King of the Accordion' is embroiled in a shocking lawsuit alleging repeated sexual assault by his band, placing a celebrated career under scrutiny.

After a regulatory clash forced its exit, crypto giant Nexo is returning to the US by leveraging Bakkt's licensed infrastructure, setting a new precedent.

Universal Health Services will present at three key March conferences, facing investors with robust profits but also cautious analyst outlooks and industry challenges.

The Northeast insurer reaffirms its commitment to shareholders with a consistent dividend ahead of its crucial year-end 2025 financial results announcement.

As Jazz Pharmaceuticals preps for key investor talks, all eyes are on its blockbuster pipeline, revenue growth, and strategy to fend off competition.

After a landmark bankruptcy, the medical giant is shoring up its finances. But can it overcome staffing shortages and shifting industry pressures?

Allegis and PDQ partner to launch SafeAxis™, bringing architectural-grade panic hardware to extreme industrial settings for enhanced safety and compliance.

Cindy Eckert's TIME100 nod follows a major FDA win for her libido drug, Addyi, but spotlights a decade-long battle over efficacy, safety, and equality.